Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 3”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Large-scale testing (Phase 3)Study completedNCT01994889
What this trial is testing

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
Pfizer 441
Not applicableEnded earlyNCT01658722
What this trial is testing

Retrieval of Patient Information After Discontinuation

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 169
Large-scale testing (Phase 3)Study completedNCT02442765
What this trial is testing

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Large-scale testing (Phase 3)Ended earlyNCT02477800
What this trial is testing

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 1,653
Large-scale testing (Phase 3)Looking for participantsNCT06585787
What this trial is testing

Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Who this might be right for
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 406
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Large-scale testing (Phase 3)Looking for participantsNCT06947941
What this trial is testing

Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Who this might be right for
Alzheimer DiseasePsychosis
Bristol-Myers Squibb 325
Large-scale testing (Phase 3)Ended earlyNCT00954590
What this trial is testing

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Moderate to Severe Alzheimer
Medivation, Inc. 89
Large-scale testing (Phase 3)Ended earlyNCT05575076
What this trial is testing

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,081
Testing effectiveness (Phase 2)Study completedNCT03817684
What this trial is testing

Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects

Who this might be right for
Alzheimer's Disease
Tetra Discovery Partners 255
Testing effectiveness (Phase 2)WithdrawnNCT05006599
What this trial is testing

SNIFF - 3-Week Aptar CPS Device

Who this might be right for
Mild Cognitive ImpairmentCognitive ImpairmentAlzheimer Disease, Early Onset
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Study completedNCT03790709
What this trial is testing

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Anavex Life Sciences Corp. 509
Large-scale testing (Phase 3)Ended earlyNCT05026177
What this trial is testing

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,125
Testing effectiveness (Phase 2)Study completedNCT03867253
What this trial is testing

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Oryzon Genomics S.A. 24
Testing effectiveness (Phase 2)Ended earlyNCT00895895
What this trial is testing

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Pfizer 526
Large-scale testing (Phase 3)Study completedNCT02541929
What this trial is testing

Fish Oil Brain Delivery Study

Who this might be right for
Brain Health
University of Southern California 31
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Large-scale testing (Phase 3)Study completedNCT05108922
What this trial is testing

Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Who this might be right for
Mild Cognitive Impairment (MCI)Alzheimer Disease
Eli Lilly and Company 148
Early research (Phase 1)Study completedNCT01565330
What this trial is testing

Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 20
Early research (Phase 1)Study completedNCT03971123
What this trial is testing

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Who this might be right for
Alzheimer Disease
Cerecin 32
Next Page